Peer Review History
| Original SubmissionJune 5, 2020 |
|---|
|
PONE-D-20-16484 Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.) PLOS ONE Dear Dr. Swain, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. It was reviewed by two experts in the field who have suggested some revisions be made prior to acceptance. If you could write a response to reviewers that would expedite revision upon resubmission. Please submit your revised manuscript by Sep 05 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols I wish you the best of luck with your revisions. Hope you are keeping safe and well in these difficult times. We look forward to receiving your revised manuscript. Kind regards, Simon Clegg, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Competing Interests section: "The authors have declared that no competing interests exist." We note that one or more of the authors are employed by a commercial company: Nofima AS. 2.1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form. Please also include the following statement within your amended Funding Statement. “The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.” If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement. 2.2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc. Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: PONE-D-20-16484 Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.) General comments: The manuscript is well written. It describes the research performed and results interpreted of the immune response of vaccinated Atlantic salmon to two sea lice vaccine groups as compared to a control quite thoroughly. Developing an efficacious vaccine to control sea lice infestations in Atlantic salmon would greatly enhance the sustainability of the Atlantic salmon farming industry globally and describing and defining the immune response as it relates to antibody and gene regulation is critical to advances in vaccine development. However, I don’t feel concluding that the results support the effectiveness of a vaccine candidate is accurate if effectiveness is defined as ‘the degree to which something is successful in producing a desired result’. The manuscript is valuable for the information presented with the specific type of vaccine candidates and vaccination strategy but conclusions should be more reflective of actual protection against sea lice infestation. Specific comments: Abstract: Lines 36 & 37: Do the overall results support effectiveness? For consideration, the following definitions are provided. Efficacy can be defined as the performance of an intervention under ideal and controlled circumstances, whereas effectiveness refers to its performance under 'real-world' conditions. Introduction: Line 59: suggest replacing might with can Line 116: correct font and delete one period Fish immunization and lice challenge It might flow better to change this section to 3 sections, Fish husbandry, Fish immunization, and Lice challenge. Also, a figure that outlines fish numbers groups and fish to tank movements would make things much clearer. Days post immunization could be described using the number of degree days post immunization??? Line 129: delete period after (24) Sampling and lice counting Line 159: was the dose of benzocaine a lethal dose? Line 163: maybe use ‘humanely euthanized’ in place of killed Gene expression studies Line 204: Should this be a larger font as it appears to be new section? Or put in with the side effects analysis Results Impact of vaccine candidate post lice infestation Lines 263 through 266: I almost think the effect of lice infestation on the fish should be its own brief section Line 286: I still feel the use of the term efficacy isn’t appropriate Global assessment: Heat map and hierarchical clustering Line 315: map should be maps Line 320: change infection to infestation Principle component analysis (PCA) Line 344: change infection to infestation Discussion Line 390: change infection to infestation Line 393: suggestion only- change ‘is still on its way’ to ‘forthcoming’ Line 394: either ‘a vaccine candidate’ or ‘vaccine candidate’ Line 394: remove comma after lead Lines 417-418: the tense of the sentence needs to be consistent, change was to is in line 417 Lines 421 -432: I do question the interpretation again of efficacy??? I do agree larger number of experimental fish are needed for evaluating efficacy. Line 425: need a period after only Line 442: delete duplicate ‘in’ Line 468: should it read ‘A microarray experiment’ or “Microarray experiments’’ Line 486: what are you suggesting in this line, did the immune priming make the response worse or did it overstimulate and exhaust the response?? Line 534: suggestion only- change ‘have in mind’ to ‘consider’ Line 537: I’m not convinced the study is ready for a field study but rather repeated with larger number of fish Reviewer #2: Mostly well done, and certainly a valuable contribution on an important topic. There are some major and minor concerns that must be addressed, but afterwards, I think this manuscript would be suitable for publication. Most importantly, I worry that the authors have used an inappropriate formula in calculating the overall vaccine effect, which leads to a misleading finding (see comment on L186). The numbers in Table 2 are fine, but in the text, the authors report 86% overall efficacy in Group 2, yet according to Table 2 there is only a 40% reduction in the number of adult females relative to the control group, and only a 23% reduction in the reproductive success of those adult females (i.e. F1 larval counts). To me this means a 54-55% reduction overall depending on whether you consider all adult females or only those with eggs. The writing is mostly easy to understand, but the quality could be further improved by some grammatical corrections throughout. Abstract Good, although I would like to see an overall effect size given in the abstract. “Good potential” could probably mean anything from 10% to 90% reduction! Introduction A good background, well done. Methods Antigen purification: I am not an expert in these methods so cannot really comment on their suitability, but I see no obvious errors. L126-127: Give a full overview of the experimental design upfront here. I also don’t see what size the experimental tanks were – 500 L seems small for 120 fish? I suggest something like “Six XXX L tanks were stocked with 120 fish each, with XXX tanks assigned to each of the 3 experimental groups: procedural control (Group 1), injected vaccine (Group 2), and injected vaccine + bath immunization (Group 3).” This way it is easier for the reader to understand the basic design and sample size at the fish and tank level. Details about the treatments and rearing conditions can come afterwards. L148: Were oxygen levels monitored during this time? Depending on the size of the tanks, oxygen levels could get very low during an hour without flow. L156: Earlier it is said that experimental groups were kept in duplicate. I assumed that to mean 2 tanks per group. Here it is 10 fish per tank = 30 fish per group, which is repeated further on in the paper. L162: It is good that counting was done this way, but how were fish sampled? My experience is that most lice are actually lost during netting and anaesthesia rather than during counting. This paragraph should say how the sampling took place. For example, were the tanks sedated before sampling (this reduces the number of lice lost during netting), were fish netted or removed some other way (again, affects how many lice are lost), were the 10 fish per tank anaesthetised together in a bucket or separately, was the anaesthetic water checked for detached lice, etc.). This shouldn’t qualitatively change the vaccine effect, but it may change our understanding of infestation density across all three groups (especially because lice levels decreased markedly over time). L172: How were the egg strings from different groups distributed across the 5 incubators? Can you be sure that differences between groups were not caused by differences between incubators? L186: This formula seems problematic to me: “Vaccine efficacy (%) = 100 x [1-(NCh x NPA x NF x NM x FE x NE x LE x CC)]”. Unless I misunderstand, it looks like repeated counting of the same effect. For example, there is no need to include the immature stages here – losses of lice at all stages will accumulate and be ultimately represented by the difference in the density of adult females. You can then multiply that effect by effects on reproductive output per female. The study cited (Rodríguez-Mallon et al. 2015) used a similar formula but using different parameters, so does not support the usage here. I also disagree with the use of egg string number (NE), as this is more likely to be a sampling artefact than a biological effect (see also L256). Moreover, wouldn’t F1 copepodid counts also incorporate differences in egg string length (LE) if that variable is important? Unless the authors can explain why this isn’t repeated counting of the same effects, I recommend using a much simpler and more defensible formula to calculate an overall effect, representing how many female lice survive to maturity and how many larvae they produce: Vaccine efficacy (%) = 100 x [1-(FE x CC)]. Note, the CC parameter should be corrected for the number of egg strings collected per female (copepod count / number of egg strings). L202: K is usually based on a simple formula, can it be included here to save the reader looking up Barnham and Baxter to find out how K was calculated? L220: “Experimental groups were conducted in triplicates”. I’m not clear on what this means for the statistical models. I would like to see a bit more explanation of how the models were specified. I assume a different model for each stage? Were there any factors other than the experimental group? Were individual fish, or tanks, treated as the unit of replication? If fish are replicates, did you test tank identity as a factor? If tanks are replicates, how were lice densities on individual fish summarised to tank level? L221: Outliers in which variable (lice levels?), and why? What was the criteria for identifying an outlier and is it biologically justified? How many were removed? Does leaving them in change the outcome? Results L234-236: Doesn’t this belong in the methods rather than results? L236: Thank you for providing SDs (not always done in aquaculture!). Can you clarify in the text at what level they were calculated? e.g. SD across all fish within a group, or across tank means within a group? Some more details on the statistical results would also improve the quality (e.g. degrees of freedom, test statistics), or else include the model outputs in the supplementary material. L256: I might have missed this, but what was done when lice had only one egg string vs two egg strings? Was this accounted for when comparing copepodid densities? Egg strings are very easily dislodged during sampling so I would correct for missing egg strings rather than considering it to be a result of the treatment. To me, there is no biological basis for the comparison of Panels E, F and G in Figure 2. It more likely to be comparing how roughly fish were handled than any effect of a vaccine. L291: Give % differences in the text here – this is an important result when considering future commercial applications. L313 onwards: Very interesting results, well done. Discussion L392-395: I’m not sure this sentence adds much of substance, I would consider deleting. L407-408: Does it make more sense to talk in terms of a cumulative effect here? L421-432: This paragraph is really difficult to follow (both the logic and the language). I suggest rewriting it in a more methodical manner. Importantly, I don’t see how a “careful analysis of formulas” affects our understanding of how well vaccines work. Ultimately, doesn’t it come down to how many lice remain attached with how well they reproduce? I guess this stems from the issues with the formula that I discuss above. Related points: L422: Replace “extrapolated” with “applied”. L430: Please add a note that a large number of tanks is also important (fish within tanks are not truly independent replicates, as they often vary together). L483 onwards: Interesting explanation. Can you also discuss how likely is that the result is spurious (due to low levels of replication at the tank level) versus the mechanisms you outline here? For example, you could point out that relative infestation densities changed over time, rather than being consistently different from day 1. Perhaps somewhere you could give the mean infestation density for every tank at the earliest possible day (I guess that would be 17 dpi?) so the reader can assess how tanks varied within groups (in more detail than SD provides). L508: I would simplify to “…reach the mobile stage on the host…”. “Mobile” is the term used almost universally used in the literature. Figures Generally okay. See comment above regarding panels E-G in Figure 2. If you want to save space in the article, the table of observations within Figure 3 could be moved to the supplement. Data I don’t see a link for data sharing – apologies if I missed it. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-16484R1 Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.) PLOS ONE Dear Dr. Swain, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Many thanks for submitting your manuscript to PLOS One It was reviewed by the same two reviewers who reviewed the first manuscript and they have suggested some more very minor modifications be made prior to acceptance If you could write a response to reviewers, that will help to expedite revision when you re-submit I wish you the best of luck with your revisions Hope you are keeping safe and well in these difficult times Thanks Simon ============================== Please submit your revised manuscript by Oct 17 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Simon Clegg, PhD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors have generally done a good job of revising the manuscript, and I have only two substantive concerns remaining (one of which still affects the overall vaccine efficacy estimate). I’m confident that both concerns can be addressed to my satisfaction. The writing could still benefit from some copy editing, but I’ll leave this for the authors and/or journal to manage. Well done to the authors for the effort they’ve put into this trial. 1) Regarding lice and egg string loss during netting Original comment: L162: It is good that counting was done this way, but how were fish sampled? My experience is that most lice are actually lost during netting and anaesthesia rather than during counting. This paragraph should say how the sampling took place. For example, were the tanks sedated before sampling (this reduces the number of lice lost during netting), were fish netted or removed some other way (again, affects how many lice are lost), were the 10 fish per tank anaesthetised together in a bucket or separately, was the anaesthetic water checked for detached lice, etc.). This shouldn’t qualitatively change the vaccine effect, but it may change our understanding of infestation density across all three groups (especially because lice levels decreased markedly over time). Authors’ response: As per reviewer suggestion, the paragraph was modified accordingly in L170-178 as mentioned below: “Fish were taken out one at a time gently by handle fishing net from the stocking tanks and transferred in a bucket containing an overdose of anaesthetic water (0.01% benzocaine). Care was taken for the minimum loss of lice through netting. The net was simultaneously checked for the detached lice. One fish per bucket was anaesthetized before lice counting. To avoid counting error of detached lice due to anaesthesia and handling, counting of chalimus at 17 dpi, pre-adults at 28 dpi and adults at 50 dpi on individual parasitized fish were performed under water in a white tray. After lice counting from each fish/tray, the remaining water in the respective tray and bucket were checked for detached lice.” Moreover, we have experienced that after sedation of fish, lice is detached very quickly from the fish. Therefore, fish were taken out first one by one through handle net and then anaesthetised in a white bucket and simultaneously the net was checked for any detached lice on the net in anaesthetic water. New comment: This is a better description of the sampling protocol, although I’m still not convinced that the authors are able to prevent loss of any lice or egg strings during netting. As I noted in my original comment, I realise that this does not matter much for the measured vaccine efficacy because all groups received the same handling, but in a study that directly concerns infestation density and infestation persistence, likely sources of lice loss during sampling should be acknowledged. It is well known that netting salmon (and especially unsedated salmon) causes some adult lice and egg strings to be dislodged from abrasion by the mesh, and netting “gently” or “with care” doesn’t change this, especially if the fish is struggling. I would therefore like the authors to include a note either acknowledging this or explaining how they can be sure that none were lost. E.g. (i) maybe the net mesh was fine enough to capture lice and egg strings that might have been dislodged, (ii) maybe they are confident that they would see any dislodged egg strings in the tank after netting (detached lice would likely reattach to another host in the tank – something I’ve seen before), or (iii) acknowledge that some lice and egg strings could have been lost before the fish was transferred to the anaesthetic bucket. A small point on wording: Change “handle fishing net” to your choice of “hand net”, “dip net” or “scoop net” 2) Regarding the vaccine efficacy formula Original comment: L186: This formula seems problematic to me: “Vaccine efficacy (%) = 100 x [1-(NCh x NPA x NF x NM x FE x NE x LE x CC)]”. Unless I misunderstand, it looks like repeated counting of the same effect. For example, there is no need to include the immature stages here – losses of lice at all stages will accumulate and be ultimately represented by the difference in the density of adult females. You can then multiply that effect by effects on reproductive output per female. The study cited (Rodríguez-Mallon et al. 2015) used a similar formula but using different parameters, so does not support the usage here. I also disagree with the use of egg string number (NE), as this is more likely to be a sampling artefact than a biological effect (see also L256). Moreover, wouldn’t F1 copepodid counts also incorporate differences in egg string length (LE) if that variable is important? Unless the authors can explain why this isn’t repeated counting of the same effects, I recommend using a much simpler and more defensible formula to calculate an overall effect, representing how many female lice survive to maturity and how many larvae they produce: Vaccine efficacy (%) = 100 x [1-(FE x CC)]. Note, the CC parameter should be corrected for the number of egg strings collected per female (copepod count / number of egg strings). Authors’ response: Taking into account the reviewer suggestion, we assumed the proposed formula of vaccine efficacy but include the parameter LE as shown below: Vaccine efficacy (%) = 100 x [1-(FE x LE x CC)]. LE: length of egg strings in vaccinated group/length of egg strings in control group. The length of egg strings are considered representative of how many eggs were produced, because it is almost impossible to count the eggs one by one. CC: F1 generation copepodids count from vaccinated group/F1 generation copepodids count in control group. It is an indicator of how many larvae are produced from a fixed amount of egg strings. We think that the correction of CC is not valid since we placed the same number of egg strings per group (50 egg strings per group divided in 5 incubation chambers with 10 egg string in each one) in the incubation chambers for hatching. With the new formula, vaccine efficacy was 58% for group 2 and 20% for group 3. This was corrected in the text. New comment: I agree with the authors that CC should not be corrected for the number of egg strings (it is now clear that the same number of egg strings were used per group). However, the inclusion of LE still seems incorrect. I agree that LE is a fair proxy for number of eggs, and is an interesting variable to measure and report in the paper, but I don’t agree with it being used in this way in the formula. This is because the CC parameter already accounts for differences in the number of eggs produced – all else being equal, fewer eggs per egg string will result in fewer F1 larvae per egg string (this contributes to the observed effect on CC). Therefore, the vaccine effect on LE is already contained within the effect on CC, and multiplying the two parameters within the same formula is double-counting the FE effect and inflating the overall effect by a few %. So I have to push for my original recommendation for the formula: Vaccine efficacy (%) = 100 x [1-(FE x CC)]. Alternatively, the authors could include FE and CC, but in a different form where LE is the effect on number of eggs produced, and CC/LE is the effect on copepodid production from a given number of eggs (not egg strings). This avoids double-counting and gives the same result as 100 x [1-(FE x CC)], but explicitly shows the importance of LE by partitioning the vaccine effects on reproduction into (i) number of eggs per egg string, and (ii) number of larvae per egg: Vaccine efficacy (%) = 100 x [1-(FE x LE x (CC/LE))] For simplicity, CC/LE could be assigned to a new parameter called, for example, CE (copepodids per egg) to simplify the formula. The formula would then be: Vaccine efficacy (%) = 100 x [1-(FE x LE x CE)]. Where FE is the effect on female survival to maturity, LE is the effect on fecundity of adult females (using egg string length as a proxy for fecundity), and CE is the effect on hatching and survival of F1 offspring to the copepodid stage. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.) PONE-D-20-16484R2 Dear Dr. Swain We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Simon Clegg, PhD Academic Editor PLOS ONE Additional Editor Comments: Many thanks for resubmitting your manuscript to PLOS One As you have addressed all the reviewer comments, and the manuscript reads well, I have recommended it for publication You should hear from the Editorial Office soon It was a pleasure working with you, and I wish you all the best for your future research Hope you are keeping safe and well in these difficult times Thanks Simon |
| Formally Accepted |
|
PONE-D-20-16484R2 Impact of a candidate vaccine on the dynamics of salmon lice (Lepeophtheirus salmonis) infestation and immune response in Atlantic salmon (Salmo salar L.) Dear Dr. Swain: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Simon Clegg Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .